Oral Drug Delivery Videos
-
PBPK Modeling: Mitigating Absorption Risks In Early Drug Development
Discover how PBPK models combined with in vitro tools and solubility enhancement expertise can be used to identify and mitigate absorption risks in early drug development.
-
Patient Safety Through Overdose Protection With Elysium Therapeutics' Greg Sturmer
11/18/2024
Drug overdoses can result both from knowingly risky behavior, such as opioid use disorder, and from unwitting patient acts of over-consumption. In this episode of Sit and Deliver, Greg Sturmer, co-founder and CEO of biopharmaceutical company Elysium Therapeutics, talks with Sit and Deliver host Tom von Gunden about ways to add overdose inhibitors to oral medications prone to abuse or misuse.
-
Rapid, Material-Sparing Feasibility Screening For Hot Melt Extrusion
Discover a screening process to quickly assess HME feasibility that yields more accurate predictions for API loading and degradation while saving material and time compared to traditional approaches.
-
Oral Small Molecule Targeting of Cancer with Cantex' Stephen Marcus
9/17/2024
Dr. Stephen Marcus boasts drug development experience across various routes of administration targeting varied therapeutic areas. Now as Cantex CEO, he leans on his background as an oncologist to drive his passion for effectively treating cancer while easing the patient experience. In this episode of Sit and Deliver, host Tom von Gunden asks Dr. Marcus about innovations in small molecule delivery for complex, life-threatening conditions.
-
Minitabs Technology
8/29/2024
Learn how this innovative system offers tailored release profiles, precise dosing, and versatile formats for your products.
-
AdvaTab Orally Disintegrating Tablet Technology
8/29/2024
Discover AdvaTab's innovative ODT technology, providing a convenient and easy-to-take dosage solution for patients of all ages.
-
Technology To Overcome Absorption Hurdles And Solubility Limitations
3/6/2024
For poorly soluble drugs, overcoming absorption hurdles can hinder development. Explore a solution that empowers researchers to overcome solubility limitations and accelerate drug development.
-
The Role of ISO 13485 in the New QMSR
7/11/2024
What does the addition of ISO 13485 as reference in the new QMSR mean for those working to comply with 21 CFR 820? In this segment of the Drug Deliver Leader Live! event New FDA QMSR: Its Role in Part 4 Compliance for Combination Products, consultant Laurie Auerbach of Compliance Prodigies explains the relationship between the two guidance documents.
-
Solvent-Free, Fusion-Based Amorphic Dispersion Process
7/11/2024
Discover a solvent-free, fusion-based process that leverages frictional and shear forces to rapidly convert crystalline drugs and polymers into amorphous solid dispersions (ASDs).
-
Bolstering Bowel And Bladder Control With Dignify Therapeutics' Karl Thor
2/6/2025
In this episode of Sit and Deliver, host Tom von Gunden talks with Chief Scientific Officer Karl Thor of Dignify Therapeutics about providing relief for patients suffering from neurogenic bowel and bladder dysfunction.